Recombinant SARS-CoV-2 spike proteins for sero-surveillance and epitope mapping
Jegouic, S. M.; Loureiro, S.; Thom, M.; Paliwal, D.; Jones, I. M.
Show abstract
The newly emergent SARS-CoV-2 coronavirus is closely related to SARS-CoV which emerged in 2002. Studies on coronaviruses in general, and SARS in particular, have identified the virus spike protein (S) as being central to virus tropism, to the generation of a protective antibody response and to the unambiguous detection of past infections. As a result of this centrality SARS-CoV-2 S protein has a role in many aspects of research from vaccines to diagnostic tests. We describe a number of recombinant forms of SARS-CoV-2 S expressed in commonly available expression systems and their preliminary use in diagnostics and epitope mapping. These sources may find use in the current and future analysis of the virus and the Covid-19 disease it causes.
Matching journals
The top 4 journals account for 50% of the predicted probability mass.
Similar papers in this journal
- Emergency Response for Evaluating SARS-CoV-2 Immune Status, Seroprevalence and Convalescent Plasma in Argentina 93%
- Neuraminidase antigenic drift of influenza A virus H3N2 clade 3c.2a viruses alters virus replication, enzymatic activity and inhibitory antibody binding 93%
- Structure and flexibility of the DNA polymerase holoenzyme of vaccinia virus 93%
Similar papers in this journal
- SARS-CoV2 mutant-specific T cells and neutralizing antibodies after vaccination and up to 1 year after infection 93%
- Crystal and solution structures reveal oligomerization of individual capsid homology domains of Drosophila Arc 93%
- SARS-CoV-2 Envelope (E) Protein Interacts with PDZ-Domain-2 of Host Tight Junction Protein ZO1 92%
Similar papers in this journal
- Interaction of human ACE2 to membrane-bound SARS-CoV-1 and SARS-CoV-2 S glycoproteins 95%
- Antibody binding to SARS-CoV-2 S glycoprotein correlates with, but does not predict neutralization 93%
- SARS-COV-2 Delta variant displays moderate resistance to neutralizing antibodies and spike protein properties of higher soluble ACE2 sensitivity, enhanced cleavage and fusogenic activity 93%
Similar papers in this journal
- A simplified SARS-CoV-2 pseudovirus neutralization assay 93%
- Surrogate virus neutralisation test based on nanoluciferase-tagged antigens to quantify inhibitory antibodies against SARS-CoV-2 and characterise Omicron-specific reactivity 92%
- Humoral responses against BQ.1.1 elicited after breakthrough infection and SARS-CoV-2 mRNA vaccination 92%
Similar papers in this journal
- The crystal structure of vaccinia virus protein E2 and perspectives on the prediction of novel viral protein folds 93%
- SARS-CoV-2 growth, furin-cleavage-site adaptation and neutralization using serum from acutely infected, hospitalized COVID-19 patients 92%
- A human adenovirus encoding IFN-γ can transduce Tasmanian devil facial tumour cells and upregulate MHC-I 92%
"Similar papers" are the closest papers from that journal in the model's embedding space. They show what the match is built on, but the ranking comes mostly from a classifier over the whole training set, not from these examples alone.